| Aberrant DNA methylation is a dominant mechanism in MDS progression to AML Y Jiang, A Dunbar, LP Gondek, S Mohan, M Rataul, C O'Keefe, ... Blood, The Journal of the American Society of Hematology 113 (6), 1315-1325, 2009 | 528 | 2009 |
| Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML LP Gondek, R Tiu, CL O'Keefe, MA Sekeres, KS Theil, JP Maciejewski Blood, The Journal of the American Society of Hematology 111 (3), 1534-1542, 2008 | 404 | 2008 |
| 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in … AJ Dunbar, LP Gondek, CL O'Keefe, H Makishima, MS Rataul, H Szpurka, ... Cancer research 68 (24), 10349-10357, 2008 | 348 | 2008 |
| Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies RV Tiu, LP Gondek, CL O'Keefe, P Elson, J Huh, A Mohamedali, ... Blood, The Journal of the American Society of Hematology 117 (17), 4552-4560, 2011 | 237 | 2011 |
| Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome MW Wlodarski, LP Gondek, ZP Nearman, M Plasilova, M Kalaycio, ED Hsi, ... Blood 108 (8), 2632-2641, 2006 | 135 | 2006 |
| Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited A Jerez, LP Gondek, AM Jankowska, H Makishima, B Przychodzen, ... Journal of clinical oncology 30 (12), 1343, 2012 | 134 | 2012 |
| New lesions detected by single nucleotide polymorphism array–based chromosomal analysis have important clinical impact in acute myeloid leukemia RV Tiu, LP Gondek, CL O'Keefe, J Huh, MA Sekeres, P Elson, ... Journal of clinical oncology 27 (31), 5219, 2009 | 129 | 2009 |
| SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD LP Gondek, AJ Dunbar, H Szpurka, MA McDevitt, JP Maciejewski PLoS One 2 (11), e1225, 2007 | 103 | 2007 |
| Donor clonal hematopoiesis and recipient outcomes after transplantation CJ Gibson, HT Kim, L Zhao, HM Murdock, B Hambley, A Ogata, ... Journal of Clinical Oncology 40 (2), 189, 2022 | 94 | 2022 |
| TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p M Jasek, LP Gondek, N Bejanyan, R Tiu, J Huh, KS Theil, C O'Keefe, ... Leukemia 24 (1), 216-219, 2010 | 90 | 2010 |
| Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation LP Gondek, G Zheng, G Ghiaur, AE DeZern, W Matsui, ... Leukemia 30 (9), 1916-1920, 2016 | 88 | 2016 |
| Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes R Tiu, L Gondek, C O'keefe, JP Maciejewski Leukemia 21 (8), 1648-1657, 2007 | 84 | 2007 |
| Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones. JP Maciejewski, C O'Keefe, L Gondek, R Tiu Folia histochemica et cytobiologica 45 (1), 5-14, 2007 | 80 | 2007 |
| Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome‐wide single nucleotide polymorphism array analysis J Huh, RV Tiu, LP Gondek, CL O'Keefe, M Jasek, H Makishima, ... Genes, Chromosomes and Cancer 49 (4), 390-399, 2010 | 76 | 2010 |
| FISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del (5q), monosomy 7, del (7q), trisomy 8 and del (20q) H Makishima, M Rataul, LP Gondek, J Huh, JR Cook, KS Theil, ... Leukemia research 34 (4), 447-453, 2010 | 73 | 2010 |
| Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients N Babel, A Vergopoulos, RU Trappe, S Oertel, MH Hammer, ... Transplantation 84 (3), 387-391, 2007 | 62 | 2007 |
| Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia Y Lim, L Gondek, L Li, Q Wang, H Ma, E Chang, DL Huso, S Foerster, ... Science translational medicine 7 (291), 291ra96-291ra96, 2015 | 61 | 2015 |
| Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes LP Gondek, AS Haddad, CL O'Keefe, R Tiu, MW Wlodarski, MA Sekeres, ... Experimental hematology 35 (11), 1728-1738, 2007 | 61 | 2007 |
| UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation H Szpurka, LP Gondek, SR Mohan, ED Hsi, KS Theil, JP Maciejewski Leukemia 23 (3), 610-614, 2009 | 60 | 2009 |
| Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states LP Gondek, AE DeZern The Lancet Haematology 7 (1), e73-e81, 2020 | 59 | 2020 |
